• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人种家族性胃癌的预后分析。

Prognostic analysis of familial gastric cancer in Chinese population.

机构信息

Department of Abdominal Surgery, Fudan University, Shanghai Cancer Center, Shanghai, China.

出版信息

J Surg Oncol. 2011 Jul 1;104(1):76-82. doi: 10.1002/jso.21896. Epub 2011 Mar 11.

DOI:10.1002/jso.21896
PMID:21400534
Abstract

BACKGROUND

The aim of this study was firstly to elucidate the prognosis of familial gastric cancer (FGC) in Chinese population.

METHODS

A total of 162 patients were recruited, including 81 patients with FGC and 81 patients with sporadic gastric cancer (SGC), who underwent gastrectomy between 1996 and 2007. Paraffin-embedded tumor specimens were obtained from tissue bank of Cancer Hospital, Fudan University. The expression of epidermal growth factor receptor (EGFR), P53, C-myc, and proliferating cell nuclear antigen (PCNA) were detected by immunohistochemical method.

RESULTS

There were significant differences in tumor size, vessel invasion, EGFR, and P53 expression between FGC and SGC patients. The 5-year survival rates were 48% and 57% in FGC and SGC patients, respectively (P = 0.033). Subgroup analysis showed that the 5-year survival rates were worse in FGC patients with nerve invasion, high PCNA expression, negative expression of EGFR, and positive expression of P53 than those in SGC group. Multivariate analysis showed that AJCC stage, tumor size, and nerve invasion were independent prognostic factors in all patients. Furthermore, AJCC stage and P53 expression dramatically affected the prognosis of FGC patients.

CONCLUSIONS

The prognosis of FGC patients might be worse than those of SGC patients. AJCC stage and P53 expression are independent prognostic factors in FGC patients.

摘要

背景

本研究旨在阐明中国人群家族性胃癌(FGC)的预后。

方法

共纳入 162 例患者,包括 81 例 FGC 患者和 81 例散发性胃癌(SGC)患者,他们于 1996 年至 2007 年间接受了胃切除术。来自复旦大学附属肿瘤医院的组织库获得了石蜡包埋的肿瘤标本。采用免疫组织化学方法检测表皮生长因子受体(EGFR)、P53、C-myc 和增殖细胞核抗原(PCNA)的表达。

结果

FGC 和 SGC 患者的肿瘤大小、血管侵犯、EGFR 和 P53 表达存在显著差异。FGC 和 SGC 患者的 5 年生存率分别为 48%和 57%(P=0.033)。亚组分析显示,FGC 患者中存在神经侵犯、PCNA 高表达、EGFR 阴性和 P53 阳性的患者 5 年生存率较 SGC 组差。多因素分析显示,AJCC 分期、肿瘤大小和神经侵犯是所有患者的独立预后因素。此外,AJCC 分期和 P53 表达显著影响 FGC 患者的预后。

结论

FGC 患者的预后可能较 SGC 患者差。AJCC 分期和 P53 表达是 FGC 患者的独立预后因素。

相似文献

1
Prognostic analysis of familial gastric cancer in Chinese population.中国人种家族性胃癌的预后分析。
J Surg Oncol. 2011 Jul 1;104(1):76-82. doi: 10.1002/jso.21896. Epub 2011 Mar 11.
2
Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.p53、nm23、增殖细胞核抗原(PCNA)及c-erbB-2在胃癌中的预后意义
Jpn J Clin Oncol. 2003 Apr;33(4):173-9. doi: 10.1093/jjco/hyg039.
3
Immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in familial clustering of gastric cancer.
J Surg Oncol. 1996 Aug;62(4):253-7. doi: 10.1002/(SICI)1096-9098(199608)62:4<253::AID-JSO5>3.0.CO;2-5.
4
[Cross-sectional study of characteristics and prognosis of patients with familial gastric cancer].
Zhonghua Yi Xue Za Zhi. 2013 Apr 23;93(16):1214-8.
5
Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer.p53指数以及增殖细胞核抗原和Ki-67在胃癌中的表达的临床相关性
J Cancer Res Clin Oncol. 1998;124(9):497-502. doi: 10.1007/s004320050205.
6
[Analysis of clinicopathological characteristics and prognosis of 91 patients with familial gastric cancer].
Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Oct;17(10):997-1001.
7
Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.胃癌中p53蛋白、c-erbB-2蛋白、表皮生长因子受体蛋白及增殖细胞核抗原的免疫组织化学检测
J Korean Med Sci. 1993 Aug;8(4):293-304. doi: 10.3346/jkms.1993.8.4.293.
8
Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.肿瘤血管生成与p53、c-ErbB2、c-myc及EGFr免疫组化作为胃癌预后因素的比较研究
Histol Histopathol. 2000 Apr;15(2):455-62. doi: 10.14670/HH-15.455.
9
Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas.
Oral Oncol. 1999 May;35(3):302-13. doi: 10.1016/s1368-8375(98)00120-1.
10
Correlation of p53 expression and proliferative activity in gastric cancer.胃癌中p53表达与增殖活性的相关性
Anal Cell Pathol. 1993 Sep;5(5):277-88.

引用本文的文献

1
A Comprehensive Review on the Importance of MiRNA-206 in the Animal Model and Human Diseases.miRNA-206 在动物模型和人类疾病中的重要性的全面综述
Curr Neuropharmacol. 2024;22(6):1064-1079. doi: 10.2174/1570159X21666230407124146.
2
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model.雷帕霉素和氟尿嘧啶协同作用治疗 PTEN 条件性缺失小鼠模型中的胃肿瘤。
Gastric Cancer. 2022 Jan;25(1):96-106. doi: 10.1007/s10120-021-01229-x. Epub 2021 Aug 9.
3
Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling.
长链非编码RNA结肠癌相关转录本2的沉默通过阻断mTOR信号传导抑制胃癌的生长和转移。
Onco Targets Ther. 2020 Jan 13;13:337-349. doi: 10.2147/OTT.S220302. eCollection 2020.
4
Prognostic value of transducer of ErbB2.1 (TOB1) expression in patients with gastric cancer: tissue microarray analysis.ErbB2.1 转导蛋白(TOB1)表达在胃癌患者中的预后价值:组织芯片分析
Int J Clin Exp Pathol. 2018 Aug 1;11(8):4060-4066. eCollection 2018.
5
MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH.微小RNA-154通过直接靶向MTDH抑制胃癌细胞的生长和转移。
Oncol Lett. 2017 Sep;14(3):3268-3274. doi: 10.3892/ol.2017.6558. Epub 2017 Jul 8.
6
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.增殖细胞核抗原表达在胃癌中的预后价值及临床病理意义:一项系统评价与Meta分析
Onco Targets Ther. 2017 Jan 10;10:319-327. doi: 10.2147/OTT.S126551. eCollection 2017.
7
Prognostic value of microRNA-126 and CRK expression in gastric cancer.微小RNA-126和CRK表达在胃癌中的预后价值
Onco Targets Ther. 2016 Oct 11;9:6127-6135. doi: 10.2147/OTT.S87778. eCollection 2016.
8
ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.ATAD2在胃癌中过表达,是一种独立的不良预后生物标志物。
Clin Transl Oncol. 2016 Aug;18(8):776-81. doi: 10.1007/s12094-015-1430-8. Epub 2015 Nov 2.
9
Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.长链非编码RNA CCAT2在胃癌中上调并与预后不良相关。
Int J Clin Exp Pathol. 2015 Jan 1;8(1):779-85. eCollection 2015.
10
Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.P21 激活蛋白激酶 2 的激活是胃癌患者的一个独立预后预测因子。
Diagn Pathol. 2014 Mar 12;9:55. doi: 10.1186/1746-1596-9-55.